Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. Issue 2 (1st June 2016)
- Record Type:
- Journal Article
- Title:
- Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. Issue 2 (1st June 2016)
- Main Title:
- Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis
- Authors:
- Lv, Wei
Chen, Na
Lin, Yanliang
Ma, Hongyan
Ruan, Yongwei
Li, Zhiwei
Li, Xungeng
Pan, Xiaohua
Tian, Xingsong - Abstract:
- Highlights: TLR4 was required for MIF-mediated migration of breast cancer cells. MIF-induced ROS generation promoted breast cancer cell migration. MIF regulates breast cancer cell migration via the ERK/HMGB1/TLR4/NF-κB pathway. MIF promoted secretion of cytoplasmic HMGB1 by activating caveolin-1. MIF overexpression enhanced lung metastasis of breast cancer in vivo. Abstract: Macrophage migration inhibitory factor (MIF) is up-regulated in diverse solid tumors and acts as the critical link between immune response and tumorigenesis. In this study, we demonstrated that MIF overexpression promoted migration of breast cancer cells by elevating TLR4 expression. Further investigation evidenced that MIF induced ROS generation. MIF-induced ROS led to ERK phosphorylation, which facilitated HMGB1 release from the nucleus to the cytoplasm. MIF overexpression also induced caveolin-1 phosphorylation. Caveolin-1 phosphorylation contributed to HMGB1 secretion from the cytoplasm to the extracellular matrix. The extracellular HMGB1 activated TLR4 signaling including NF-κB phosphorylation, which was responsible for the transcription of Snail and Twist as well as MMP2 activation. Furthermore, MIF-induced caveolin-1-dependent HMGB1 secretion might control the recruitment of CD11b+ immune cells. Our data suggested that MIF affected the intrinsic properties of tumors and the host immune response in tumor microenvironment by regulating the TLR4/HMGB1 axis, leading to metastasis of breast cancer.
- Is Part Of:
- Cancer letters. Volume 375:Issue 2(2016)
- Journal:
- Cancer letters
- Issue:
- Volume 375:Issue 2(2016)
- Issue Display:
- Volume 375, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 375
- Issue:
- 2
- Issue Sort Value:
- 2016-0375-0002-0000
- Page Start:
- 245
- Page End:
- 255
- Publication Date:
- 2016-06-01
- Subjects:
- Macrophage migration inhibitory factor (MIF) -- Breast cancer -- Metastasis -- TLR4 -- HMGB1
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2016.02.005 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8090.xml